Archangels raises €14M to empower Scotland’s aspiring entrepreneurs and innovators
Archangels says it will combine capital from British Business Investments with syndicate funding for its investment activity.
Popular topics
Contributor
Vishal Singh is a News Reporter and Social Media Marketing Lead at Silicon Canals. He covers developments in the European startup ecosystem and oversees the publication's social media presence. Before joining Silicon Canals, Vishal gained experience at the Indian digital media outlet Inc42, contributing to its growth with insightful content. Despite being a college dropout, his passion for writing has driven his career in journalism.
Archangels says it will combine capital from British Business Investments with syndicate funding for its investment activity.
Aug 1, 2023
Grasp aims to accelerate human learning.
Jul 31, 2023
Percayso Inform claims to offer advanced insurance intelligence that goes beyond traditional data enrichment.
Jul 31, 2023
Finst has also announced a welcome offer in which all new clients who complete their registration before the end of August will be able to trade their first €10,000 for free for two weeks.
Jul 31, 2023
Entia will fund its flagship product, Liberty - a complete remote patient monitoring solution for those receiving cancer treatment - across the UK and the US.
Jul 27, 2023
AutogenAI’s software generates substantial savings for businesses and governments by reducing bidding costs.
Jul 27, 2023
Materials Nexus aims to develop next-generation materials for daily things that are environmentally friendly.
Jul 26, 2023
AgStacked aims to address the critical challenges of fresh produce supply chain quality disputes, claims, and food waste.
Jul 26, 2023
Vendora has established itself as Greece’s “premier” horizontal classifieds marketplace, offering a wide range of commodities in a variety of categories.
Jul 26, 2023
Bpifrance is a public investment bank that supports companies from seed to stock market listing, from credit to equity.
Jul 25, 2023
GenSensor seeks to advance the research, manufacture, and use of novel medicines by reindustrialising their production in France and, more widely, by becoming a vital partner for innovators in the pharmaceutical industry.
Jul 25, 2023
The investors in this round include Ali Niknam (Founder of bunq), Pollen Street Capital and Raymond Kasiman.
Jul 24, 2023